BioCentury
ARTICLE | Company News

EMA accepts ospemifene MAA for review

March 28, 2013 12:13 AM UTC

Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507) said EMA accepted for review an MAA for ospemifene to treat postmenopausal vulvovaginal atrophy. Shionogi has exclusive, worldwide rights, excluding undisc...